A Trial to Learn How Safe AZD9550 Monotherapy and Combined With AZD6234 is in People With or Without Type 2 Diabetes Who Are Living With Obesity and Overweight

NCT06151964 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight and Obesity

Interventions

DRUG: AZD9550
DRUG: placebo
DRUG: AZD9550 and AZD6234

Sponsor

AstraZeneca